March 6, 2018 5:24pm
The sector opened up, slipped at 11 a.m. resumed to the up-side at the mid-day as the 1:30 p.m. mark flickered again to closed positive
Uncertainty is in the air
Pre-open indication results: 2 HITs and 2 MISS
Research notes: 2 HITs and 0 MISS
Q4 and FY17 results: Regenxbio’s (RGNX +$0.25) Q4 net loss was $16 million or -$0.51 with FY17’s $73.2 million or $2.45 per share. Adverum Biotechnologies (ADVM -$0.05) Q4 net loss was $14.8 million or -$0.32 with FY17’s $56.1 million or $1.29 loss per share.
Interpretation, insight and translation after the pre-open thesis … an end-of-day recap of the sessions impact, settlement with a little prognosis of what could or should happen next thrown in.
I define insight from a real-time perspective discussing equity share pricing, attractiveness and support levels as stock pricing changes by the hour … if not the minute!
Henry’omics:
From the pre-open’s newsletter, “… this sector is short-term oriented. What we invest in needs to be based on what we get from it … So who is keeping you and your portfolio rich and replenished? It is certainly NOT a long-term scenario.”
Equities struggled for direction throughout the day as investors questioned whether the sector will stay up or head down – interesting BLUE was up down for most of the day to close up in the last hour +$3.85.
The sector is TESTING the highs and resistances … look out below!
Again volume is low yet, higher in a few cases experiencing upside moves (BLUE, CLBS, IMUC, FCSC and SGMO as well as the downside – ADVM, FATE and VCEL.
The advance/decline line scenario of 40 SCGT & RT covered companies:
- The open was positive with an A/DL of 26/12 and 2 flat ;
- 11 a.m. was negative with an A/DL of 17/19 and 4 flats;
- The mid-day flipped back positive the A/DL to 23/16 and 1 flat;
- 1:30 slipped bawith an A/DL of 20/19 and 1 flatrely positive
- The close was positive with an A/DL of 22/13 and 5 flat;
Pre-open indication results: 2 hits and 2 miss
- Aduro Biotech (ADRO) closed up +$0.10 – hit;
- bluebird bio (BLUE) closed UP +$3.85 – miss;
- Fate Therapeutics (FATE) closed down -$0.82 – miss;
- Vericel (VCEL) closed down -$0.15 – hit;
Research notes:
- Caladrius Biosciences (CLBS) closed up +$0.45 – hit;
- Fibrocell (FCSC) closed up +$0.027 – hit;
The shifting sands of appreciation and depreciation:
The come-back sector stocks: AGTC (+$0.25), ADRO (+$0.10) and CLLS (+$0.65)
Downers: PSTI (-$0.03) and BTX (-$0.10)
Not surprised: MDXG (+$0.45)
Need financing: CAPR (-$0.01), MESO (-$0.46), VCEL (-$0.25),
Falling from the high wire: FATE (-$0.71), QURE (-$0.96), RENE.L (-$0.50 post reverse split)
Undervalued: needs news: VSTM (+$0.00) and ONVO (+$0.03)
Surprised by: VTGN (+$0.15), ATHX (+$0.01), OSIR (+$0.31), BLCM (-$0.01),
In the last hour: ADVM (-$0.05), AXGN (+$0.03), BLUE (+$3.85), RGNX (+$0.25), STML (-$0.40) and SGMO (+$1.15),
Trading games: BCLI (-$0.04), BSTG (-$0.04), CYTX (-$0.01) and NWBO (+$0.00), KOOL (-$0.05)
MY working trend lines:
… The greatest volume to the downside: VCEL, FATE, BTX, CYTX and BLCM
… Upside volume was weighted to: IMUC, SGMO, MDXG, CLBS and VTGN
… Biggest $ downside: QURE (-$0.96), FATE (-$0.71), RENE.L (-$0.50), MESO (-$0.47) and STML (-$0.40)
… Largest $ upside: BLUE (+$3.85), SGMO (+$1.15), CLLS (+$0.65), CLBS (+$0.45) and MDXG (+0.45)
… Flat: VSTM, AST, HSGX, and PSTI
Daily analytics:
U.S. stock indexes closed slightly higher on Tuesday, with the NASDAQ leading the pack.
- The Dow picked up 9 points to 24,884.
- The S&P 500 added 7 points, or 0.3%, to 2,728.
- The NASDAQ advanced 41 points, or 0.6%, to 7,372.
The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market,
- Tuesday traded at 18.36, down -1.98%
- Monday traded at 18.73, down -4.39% …
- Friday traded at 19.59, down -12.82% …
- Thursday traded 22.47, up +13.2% …
- Wednesday traded at 19.84, up +6.72% …
- Last Tuesday traded at 18.59, up +17.66% …
The iShares Russell 2000 (IWM) indicated:
- Tuesday was up +1.06%
- Monday +0.85%
- Friday +1.57%
- Thursday -0.31%
- Wednesday -1.53%
- Last Tuesday -1.45%
The iShares NASDAQ Biotechnology (IBB) indicated:
- Tuesday was up +0.26%
- Monday +1.10%
- Friday +2.44%
- Thursday -0.96%
- Wednesday -1.83%
- Last Tuesday -1.25%
The count - decliners versus gainers:
……. look at the differences in decliners:
- Tuesday’s decliners ranged from -0.13% <BLCM -$0.01> to -6.09% <MESO -$0.47> in 13 equities;
- Monday’s decliners ranged from -0.34% <RGNX -$0.10> to -3.17% <XON -$0.51> in 12 equities;
- Friday decliners ranged from -0.21% <CLBS -$0.01> to -3.77% <BSTG -$0.12> in 7 equities;
- Thursday’s decliners ranged from -0.02% <JUNO -$0.02> to -5.74% <CYTX -$0.0198> in 24 equities;
- Wednesday’s decliners ranged from -0.21% <CLBS -$0.01> to -6.41% <AXGN -$2.00> in 25 equities;
- Last Tuesday’s decliners ranged from -0.31% <VSTM -$0.01> to -6.01%% <SGMO -$1.50> in 24 equities;
Versus
… Look at the percentage’s (%) and spreads …
- Tuesday’s gainers ranged from +0.16% <ONCE +$0.10> to +20.70% <IMUC +$0.06> in 22 equities;
- Monday’s gainers ranged from +0.08% <QURE +$0.02> to +41.92% <VCEL +$3.50> in 27 equities;
- Friday’s gainers ranged from +0.14% <JUNO +$0.12> to +24.73% <XON +$3.19> in 30 equities;
- Thursday’s gainers ranged from +0.28% <MDXG +$0.02> to +16.27% <AXGN +$4.75> in 14 equities;
- Wednesday’s gainers ranged from +0.16% <JUNO +$0.14> to +9.63% <BSTG +$0.29> in 14 equities;
- Last Tuesday’s gainers ranged from +0.03% <JUNO +$0.03> to +5.84% <PSTI +$0.08> in 15 equities;
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
